Cizzle Biotechnology (LON:CIZ) Announces Quarterly Earnings Results

Cizzle Biotechnology (LON:CIZ) issued its quarterly earnings results on Wednesday. The company reported GBX (0.08) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Price Performance

Shares of CIZ stock opened at GBX 1.47 on Thursday. The business has a fifty day moving average of GBX 1.66 and a 200 day moving average of GBX 2.23. Cizzle Biotechnology has a 1 year low of GBX 1.20 and a 1 year high of GBX 3.90. The firm has a market capitalization of £6.23 million, a price-to-earnings ratio of -8.62 and a beta of 0.02.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.